In contrast, the improved survivals seen with high AIM2 and high NLRC4 were retained in patients with high or low TILs score suggesting the beneficial effect might be intrinsic to melanoma cells and independent of TILs level (Figure 3b). The gene discussed is AIM2; the disease is melanoma.